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filling problem. To objectivate left ventricular volume changes during
HD and AP drop, we investigated 2 pts free from valvulopathy or
contraction disorders exhibiting a major AP fall, in both we simulta-
neously recorded the usual hemodynamic parameters, thermodilution
(TD), cardiac output (CO), and left ventricular volumes by time motion
(TM) and two dimensional (2D) echocardiography. Seven different
recordings during the same I-ID session for each Pt show that: (1)
Ultrafiltration reduces filling pressures and left ventricular end-diastolic
(LVEDV), end-systolic (LVESV) and stroke (1.VSV) volumes without
significant variation of heart rate, ejection fraction (LVEF), or vascular
resistance. (2) During the acute AP drop, the LVESV is minimal and the
LVEDV decrease creates a fall in LVSV and in CO. (3) The injection of
hypertonic NaCI corrects filling pressures, raises LVEDV, LVSV, and
thereby CO and AP. (4) The LVSV calculated in TD and in 2D correlate
well (r 0.99 for the first pt, r = 0.96 for the second). Conclusion. The
AP drop during HD is due to a fall in LVSV secondary to LVEDV
reduction without possible LVESV variation. No major LVEF reduc-
tion was noted during AP drop.
Demography of analgesic nephropathy in Belgium. J. L. Vanher-
weghem and D. Even-Adin. Cliniques Universitaires de Bruxel/es,
Hdpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Incidence of analgesic nephropathy (AN) in the various Belgian prov-
inces was evaluated by questioning all the dialysis units in the country.
The results were analyzed in view of the distribution of the analgesic
market in Belgium. Belgium includes nine provinces and a total
population of 7.5 X 106 adults. Of 49 dialysis units for adults, 46 have
answered. Of the 1,400 patients treated in these units, 258 (18%) had
AN. However, AN averages only 3% in Europe according to the
European Dialysis and Transplant Association. In each Belgian prov-
ince, correlation between number of inhabitants and number of patients
with terminal renal failure of any etiology is better (r = 0.93, P < 0.001)
than the same correlation with the number ot'AN patients (r = 0.67, P <
0.025). This observation suggests the influence of a local factor in the
incidence of AN in Belgium. Furthermore, AN is more frequent in the
province of Antwerpen than in the other Belgian provinces (97 AN/106
inhabitants vs. 23 AN/b6 inhabitants, P < 0.001). Each year in
Belgium, 23.6 x 106 boxes of analgesics are sold, which represent 235
tons of analgesics (31 g/adult/yr), 50 tons of phenacetin (7 g/adult/yr) as
well as an expense of 27 106 US dollars. Three of the five most popular
medications in Belgium are analgesics. Interestingly, these three anal-
gesics are all made in the province of Antwerpen. Conclusion. Terminal
renal failure due to analgesic nephropathy is more common in Belgium
than it is in most countries in Europe. The disease is especially more
frequent in the province of Antwerpen where the three most popular
Belgian analgesics are made.
Acetate-induced myocardial depression in hemodialysis. J. L. Vincent,
J. L. Vanherweghem, J. P. Degaute, J. Berre, P. Dufaye, and R. J.
Kahn. Cliniques Universitaires de Bruxelles, Hôpital Erasme, tiniver-
site Libre de Bruxelles, Brussels, Belgium. Previous studies suggest that
ultrafiltration (hF) is better tolerated during dialysis with bicarbonate
(D-Bic) than with acetate (D-Ac). To clarify the causes of this discrep-
ancy, we studied the hemodynamic course of five critically ill patients
during hemodialysis for acute renal failure. In each patient, one D-Bic
and one D-Ac were performed in a randomized order. Initial plasma
volumes, measured by '31l-serum albumin, were comparable before D-
Bic (55.8 6.2 nil/kg) and before D-Ac (53.1 4.6 mI/kg). We set UF at
1,750 ml in 2 hours, while arterial mean pressure (Pa) was maintained
above 70 mm Hg by saline infusion. Negative fluid balance averaged
1,710 40 ml in D-Bic but only 1,280 210 ml in D-Ac. Decreases in Pa
and cardiac output (CO) were more significant during D-Ac than during
D-Bic (Table). A moderate increase in heart rate (HR) was observed
only during D-Ac (P < 0.05).
Before End
Pa, mm Hg 103 t I 85 5 ItO tO 75 8
PPAO, mm Hg 16.4 1.9 10.0 1.4 14.6 2.6 9.4 1.0
CO. liters/mm 6.7 0.7 5.0 0.6 6.5 0.7 4.5 0.4
HR. beats/tam 90 4 92 3 101 8 116 II
LVSW g rn/beat 84 4 53 6 82 6 34 3
Therefore, differences in left ventricular stroke work (LVSW) between
D-Bic and D-Ac emerged at the end of the UF (P <0.025) and were still
evident 30 mm after the end of the dialysis (74 6 vs 53 4g rn/beat,
P < 0.025). Since changes in pulmonary artery balloon-occluded
pressure (PpAO) were comparable in the two groups, striking myocardi-
al depression appeared from the left ventricular function curve during
D-Ac. Myocardial contractility was unaffected during D-Bic. There-
fore, poor tolerance to fluid extraction during D-Ac as compared to D-
Bic is related to myocardial depression due to acetate.
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Pretreated canine renal allograft: Survival enhanced by a local immu-
nosuppressive effect in the grafted kidney. H. L. F. Brom, J. L. Terpstra,
and P. J. C. van Breda Vriesman. Dept. of Surgery and Pathology,
Leiden University Hospital, and Dept. of Immunopathology, Bio,n cdi-
cal Centre, University of Li,nburg, The Netherlands. Clinical pretreat-
ment of the donor with cyclophosphamide (Cy) and methyl prednisone
(P) has been reported to enhance cadaveric renal allograft survival, but
it has also been reported to be void of effect. We examined the effect of
donor pretreatment with dosages of Cy and P of 100 mg/kg each and a
duration of donor pretreatment (5 hours) identical to that reported to be
effective clinically in dogs, because this species resembles man in terms
of cyclophosphamide metabolism and steroid resistance. A 5-hour
period of donor pretreatment abolished proliferative capacities of the
peripheral blood leukocytes in mixed leukocyte culture. Donor pre-
treatment of DLA and MLR histoincompatible Beagle renal allografts
resulted in a prolonged survival of 17 1.8 days (control9 1.8 days).
This effect was not strain-specific, for donor pretreatment mongrel
kidneys inserted in Beagles also showed prolonged survival of 17.0
3.1 days (controls, 8.8 2.6 days). Donor pretreatment with methyl
prednisolone alone had no significant effect on survival (10.1 4.3
days, P = 0.3), indicating that cyclophosphamide mediated the effect of
donor pretreatment mainly. Since cyclophosphamide metabolites are
excreted by the kidney, metabolites are carried over in the renal
transplant. In order to assess the contribution of these metabolites to
donor pretreatment-mediated enhanced renal allograft survival, the
metabolites were flushed out of donor pretreated kidneys by means of
mannitol-induced osmotic diuresis, either initiated in the donor 60 mm
prior to donor nephrectomy or initiated in the recipient at the time of
recirculation of the graft. Mannitol infusions given to the donor
abolished the effect of donor pretreatment (survival, 7.2 1.5 days) as
D-Bic (N = 5)
Before End
D-Ac (N = 5)
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did mannitol infusions given to the recipient (survival 8.2 2.2 days).
The effect of donor pretreatment did not appear to be mediated by a
systemic effect on the recipient by drugs transplanted in the donor
pretreated kidney for two reasons. Studies using C-cyclophosphamide
showed about 10 mg of cyclophosphamide metabolites to reside in a
well-perfused donor pretreated kidney, which is not sufficient to exert a
systemic effect. In addition, passive transfer of autologous lymphocytes
not pretreated to recipients of donor pretreated kidneys failed to abolish
the enhanced survival. These results showed the effect of donor
pretreatment to be mediated by a local effect in the graft.
Relationship between mesangial function and development of focal
sclerosis in the rat. J. Grond, M. S. Schilthuis, and J. D. Elema.
Department of Pathology, University of Groningen, Groningen, The
Netherlands. In aging male Wistar rats, glomerular lesions develop that
bear great similarity to the so-called focal segmental glomerular hyalin-
osis and sclerosis (FSGHS) in man. Unilateral nephrectomy in the rat
hastens the development of FSGHS lesions in the remaining kidney.
The glomerular mesangium may be considered as an arteriolar wall
beneath a highly permeable endothelium, and FSGHS may represent a
glomerular form of atherosclerosis. The reason for the typical segmen-
tal character of the FSGHS lesions, however, is not clear. In experi-
ment A, we investigated whether the localization of the FSGHS lesions
could be related to local changes in mesangial handling of macromo-
lecular substances. Five male wistar rats aged 3 months underwent
right-side nephrectomy. Two weeks after operation, they received
weekly iv. injections of 30 mg of colloidal carbon per 100 g of body wt
during a 3-week period. Five controls underwent sham operation. After
4 months, the animals were killed. Glomeruli with FSGHS lesions
showed carbon accumulations within and around the lesions. Semi-
quantitative analysis on a 0 to 3 + scale revealed that normal glomeruli
after nephrectomy contain more carbon than after sham operation.
Moreover, glomeruli with FSGHS lesions contain more carbon than
normal glomeruli in the same kidneys with preferential localization of
colloidal carbon in FSGHS lesions. In experiment B, the question
whether the identical localization of carbon particles and FSGHS
lesions found in experiment A were the consequence of increased local
delivery or of local disturbed mesangial macromolecular clearance, was
considered. Ten rats received weekly i.v. injections of 30 mg of carbon
per 100 g of body wt during 3 weeks. Two days after the last injection, 5
rats underwent nephrectomy, the others sham operation. It is well
known that mesangial carbon amount reaches a maximum 24 to 32
hours after injection and gradually decreases thereafter over a period of
months. After 4 months, all rats were killed. No preferential carbon
localization was found in FSGHS lesions, and equal amounts of
mesangial.carbon were found both in normal glomeruli of controls and
normal and diseased glomeruli after nephrectomy. A local increased
mesangial delivery of carbon seems to precede development of FSGHS
lesions and may reflect increased local deposition of circulating sub-
stances such as low-density lipoproteins leading to the development of
FSGHS.
Combined intravenous administration of diazoxide and a beta-adrener.
gic receptor blocking agent in the acute treatment of hypertension. F. T.
M. Huysmans, T. Thien, andR. A. P. Koene. Department of Medicine,
Division of Nephrology, Sint Radboud Hospital, University of Nzjme-
gen, Nzjmegen, The Netherlands. We studied prospectively the effects
of diazoxide infusion (5 mg/kg, 15 mg/mm) combined with slow i.v.
injection of a beta-blocker (propranolol, 0.20 mg/kg, or metoprolol, 0.25
mg/kg) on blood pressure, heart rate (HR), and plasma renin activity
(PRA) in 29 untreated patients with severe hypertension (N = 14) or a
hypertensive crisis (N = 15). Results are expressed in means SEM.
After the administration of diazoxide (N = 13), mean arterial pressure
(MAP) decreased gradually by 16.1 2.1%, whereas HR and PRA
increased by 27.3 4.1% and 48.9 13.0%, respectively. When a beta-
blocker was administered at 90 mm after the start of the diazoxide
infusion, only the systolic blood pressure (—7.2 2.3%) decreased
despite a large decrease of HR (—25.6 2.2%) and of PRA (—17.1
5.9%). After administration of the beta-blocker as the first drug (N =
16), it was again only the systolic blood pressure that decreased (—6.1
1.3%), whereas now HR decreased by 18.9 1.8% and PRA by 24.4
4.4%. Diazoxide infusion 60 mm after this beta-blockade resulted in a
further, gradual decrease of MAP of 21.9 1.9%, whereas HR (+17.1
2.6%) and PRA (+31.7 17.0%) increased to pretreatment levels.
Thus, administration of a beta-blocker after the diazoxide infusion
results in a small extra fall of systolic blood pressure despite strong
inhibition of the diazoxide-induced rise in HF and PRA. Administration
of a beta-blocker before diazoxide prevents the phase of high HR,
induced by the vasodilator. Consequently, beta-blockade during dia-
zoxide infusion might reduce the risk of myocardial ischemia. There-
fore, it is advisable to administer a beta-blocker before diazoxide
infusion in the acute treatment of hypertension.
Plasmafiltration in the treatment of Goodpasture's disease. R. T.
Krediet, C. Oldenbroek, P. Bakker, A. G. Balk, and L. Arisz. Univ.
Dept. of Medicine, Binnengasthuis, and Univ. Dept. of Pathology,
Wilhelmina Gasthuis, Amsterdam. A 23-year-old male with Goodpas-
ture's disease was treated with prednisone, 80 mg daily, azathioprine,
and plasma exchange by means of filtration (PF) through a hollow-fiber
module (Asahi Plasmaflo). The membrane is composed of cellulose-
diacetate, and molecules up to a mol wt of 3 million daltons are
removed. PF was carried out 23 times. During each procedure five liters
of plasma filtrate were obtained and replaced by a purified plasma
derivate. Anti-GBM antibodies in serum and filtrate were determined
by a radioimmunoassay. The table shows the highest and the lowest
serum values:
Highest value Lowest value
anti-GBM, % 45 0
IgG, g/liter 9.5 0.32
1gM, g/liter 6.8 0.06
C3, g/liter 1.3 0.12
Fibrinogen, gtliter 5.1 0.03
Sodium, m 137 108
Treatment resulted in rapid improvement of pulmonary disease. Renal
function was normal initially (GFR, 98 mI/mm), but deteriorated and
temporarly haemodialysis was required. A followup renal biopsy I
week after the start of the treatment showed no increase in the
percentage of crescents. After 21 days, renal function started to
improve. The glomeruli were unchanged, but at this time there was
marked tubular degeneration. It was uncertain, whether these tubular
changes were related to a transient period of sodium depletion (see
table), part of the natural course of the disease, or to the PF itself. PF
was discontinued, and GFR gradually improved to 63 mI/mm 8 months
after the beginning of the disease; anti-GBM antibodies remained
undetectable in the serum. It is concluded that PF through a cellulose
diacetate membrane is a simple procedure, which is equally effective as
plasmapheresis in the removal of anti-GBM antibodies from the circula-
tion. The effect on pulmonary disease and glomerulonephritis in Good-
pasture's disease seems comparable.
Paradoxes in a patient with Bartter's syndrome. P. W. de Leeuw, B. C.
van Pelt, G. G. Wolvius, J. ngelhardt, and W. H. Birkenhager.
Zuiderziekenhuis, Dept. of Medicine a,4 Pediatrics, Rotterdam, The
Netherlands. In a 12-year-o14 boy with Bartter's syndrome, cardiac
output (impedance method) and rna1 blood flow ('251-hippuran clear-
ance) were determined. Both variables appeared to be reduced, from
which it could be inferred that total peripheral and renal vascular
resistance were increased. Renin and aldosterone were increased also.
Infusion of angiotensin 11 (All) caused peripheral and renal vascular
resistance to rise further; this was accompanied by increments of renin
and aldosterone. However, blood pressure did not change since cardiac
output was reduced. Acute administration of indomethacin reduced
renal (cortical) blood flow and aldosterone, but stimulated renin. During
chronic treatment with indomethacin, a prompt and sustained fall of
both renin and aldosterone was noted. Cardiac ouptut increased slight-
ly, but renal blood flow remained unchanged. Blood pressure and
vascular resistance increased. During the next 3 years, this pattern
remained unchanged. Infusion of A!!, after 1 and again after 3 years of
treatment, induced a fall in peripheral vascular resistance; cardiac
output increased, but renin and renal blood flow did not change. These
data suggest that in Bartter's syndrome the vessel wall is not hypore-
sponsive to the action of All; the absence of a rise in blood pressure
presumably is due to volume depletion. However, a positive feed-back
mechanism exists between renin and angiotensin, which may be of
pathophysiologic significance. After inhibition of prostaglandin synthe-
sis, angiotensin appears to be able to induce vasodilation. This phenom-
enon cannot be satisfactorily explained at the moment. The results are
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reminiscent of our data obtained in dogs on which we reported earlier
for this Society. As a hypothesis one could think that there are different
classes of angiotensin receptors.
Transplant survival after HLA-A and -B compatible blood transfu-
sions. M. J. Nubé, G. G. Persijn, M. W. KaIff, and J, J. van Rood, St.
Elisabeth Hospital, Alkmaar, The Netherlands, and University Hospi-
tal, Leyden, The Netherlands. It is generally accepted that pretrans-
plant blood transfusions prolong transplant survival. The optimal
number, however, is not known. Some authors found better transplant
survival after increasing the number of transfusions, but the greater the
number of transfusions, the greater the probability of the formation of
cytotoxic antibodies. The presence of lymphocytotoxic antibodies can
actually be harmful for the graft. Therefore, a prospective trial was
started in 1977. Twenty dialysis patients received two or three transfu-
sions with HLA-A and -B compatible blood at 3-week intervals. At
tegular intervals, blood was taken for screening procedures. There are
two control groups. The first, historical, control group consists of
patients who were transplanted before 1977 in the same center and did
not receive any blood transfusions before the transplantation proce-
dure. The second, prospective, control group consists of patients who
were transplanted before and after a patient from the protocol group.
All patients from the prospective control group received random blood
transfusions. In August 1980, 14 out of the 20 protocol patients received
transplants and had a followup of more than 3 months. In one case, the
only female patient, transpiantectomy was performed after 3 months
because of rejection. Transp'ant survival after 3 months is 94% and
patient survival 100%. The difference in transplant survival between the
protocol group and the historical control group is significant. There is a
slightly better transplant survival in the protocol group compared with
the prospective control group, although no statistical difference can be
reached. Between the protocol group and the prospective control
group, there were no remarkable differences in the mean number of
rejection periods, or in the actuarial patient survival. Kidney function,
as defined by mean creatinine clearance, showed hardly any difference
at 3 months, but after 1 year there was a much greater difference: 38.5
mI/mm for the prospective control group (N = 7) and 68 mI/mm for the
protocol group (N = 4). The mean number of days that patients
remained in hospital was 65.4 for the prospective control group (N =
14) and 50.5 for the protocol group (N = 7). On the basis of these
preliminary data, one could speculate about the mechanism responsible
for the "transfusion effect." Considering the data of Persijn, who
showed that patients who received filtered blood (which does not
contain any leukocytes) have the same bad transplant survival as
patients who did not receive any blood transfusions, it appears that
leukocytes play some role in the favorable effect of blood transfusions.
The data presented here seem to favor the influence of non-HLA-A and
-B antigens on leukocytes.
'4CoxJic acid clearance: Comparison of the standard clearance tech-
nique to the single-injection techniques and constant-infusion technique.
J. A. C. Prenen, P. Boer, E. J. Dorhout Mees, and H. Y. Oei.
University Hospital, Utrecht, The Netherlands. On ten healthy volun-
teers, the '4C-oxalic acid clearance was measured simultaneously by
the standar4 clearance and constant-infusion technique. No significant
difference was found, indicating that no extra renal clearance occurred.
In six volunteers, the standard clearance technique was preceded by the
single-injection technique. Both with the open one-compartment model,
and the open two-compartment model, the '4C-oxalic acid clearance
was overestimated as compared to the standard clearance technique, 52
and 30%, respectively (see Table). The clearance values obtained with
the single-injection technique with urine collection were only in the last
30 mm period (four 30-mm sampling periods) comparable to those with
the standard clearance technique. The single-injection clearance tech-
niques will therefore result in less reliable derived data.
°C-oxalic acid clearance, mi/rein
Standard Single-injection Single-injection Single-injection Constant-infusion
clearance one-compartment two-compartment with urine clearance
technique model model collections technique
258 26
>0-I
Mean SD 261 23 395±36 339 28 266 31
P <000! <0.006 >0.1
Mean
overestimation 52% 30% NS NS
were obtained by SIndent's t test for paired data (N 6).
Inhibition of calcium release by diazoxide. J. F. G. Slegers, M. T. G.
Förster, and W. M. Moons. Department of Physiology, University of
Nzjmegen, Njjmegen. The Netherlands. Isolated rat kidneys were
perfused at a constant perfusion flow. Addition of barium (0.1 to 1.0
mmoles) resulted in a sharp increase in perfusion pressure, indicating
that renal vascular resistance was increased. This increase in vascular
resistance was maximal at 1.0 mmoles of barium, while calcium had no
effect at all. In kidneys of spontaneously hypertensive rats, the re-
sponse to barium was larger as compared with the effect in normoten-
sive ones. When calcium was omitted from the perfusion fluid, the
barium contractures could still be evoked but they became gradually
smaller (t0.5 value = 8 mm). In kidneys of hypertensive rats, this value
was 24 mm. These results suggest that barium liberates calcium from
intracellular stores and that these stores are more filled during hyper-
tension. Diazoxide inhibited the induced barium contractures fast,
completely reversible, and dose dependently. However, the interaction
between diazoxide and barium was of noncompetitive behavior. The
same results were obtained when vasoconstriction was generated by
high potassium concentrations (40 mmoles) in the presence of calcium.
If, however, the kidneys were perfused with a calcium-free solution and
the intracellular calcium stores were depleted by barium stimulation,
then depolarization (high potassium) resulted into a slow developing
increase in vascular resistance which could not be inhibited by diazox-
ide. Since the refilling process of the calcium stores was not disturbed
by diazoxide the results suggest that: (a) for the action of diazoxide
normally filled intracellular calcium stores are needed, and (b) that
diazoxide inhibits the calcium release process from these stores.
Measurement of renal blood flow in men with the 81Rb/81n5Kr ratio. D.
de Zeeuw, G. van Herk, A. J. M. Donker, M. G. Woldring, and G. K.
van der Hem. University Hospital, Department of Internal Medicine,
Renal Unit, Groningen, The Netherlands. The stRb/stmKr ratio method
is based on the following theory. Intravenously injected rubidium-81, a
potassium analogue, concentrates predominantly in the kidneys and
muscle tissue. Here the radioactive rubidium-81 continuously gener-
ates, by its decay, the radioactive inert gas krypton-81m. The 8ImKr
formed diffuses over the organ and is washed out by the organ blood
flow. Thus, the ratio of the activities of 81Rb and stmKr measured over
the organ, is proportional to the amount of blood flowing through the
organ per unit tissue mass and per unit time. Indeed, several experimen-
tal studies on dogs had shown the 8lRb/slmKr ratio to be an accurate
measure of the blood flow of an extracorporeal kidney. Further studies
in animals and human volunteers were performed to test the value of the
sIRb/mKr method on kidneys in situ. The OIRb/mKr method ap-
peared to be quite adequate in monitoring qualitative blood flow
changes of the in situ dog kidney with two opposite Nal detectors.
However, the relative increase of background rubidium activity during
the experiment interfered with the quantitative aspects of the blood
flow measurement. This could only be eliminated by an estimated
background subtraction. Gamma-camera measurement of the abdomi-
nal distribution of intravenously injected 8Rb in a volunteer showed an
initially high uptake in the kidneys, followed by a gradual homogeneous
redistribution of the tracer over the abdominal tissues. This study again
indicated the need for an adequate background correction when mea-
suring quantitative RBF changes with the slRb/sImKr ratio by Nal
scintillation detectors. Two further human studies were performed
measuring the 8IRb/8ImKr ratio with Nal detectors during alleged renal
blood flow changes. A pressor-dose of angiotensin I caused a decrease
of renal perfusion according to the registered fall of the Rb/Kr ratio. The
Rb/Kr ratio (corrected for background activities) restored to preinfu-
sion values after the angiotensin infusion had been stopped. The second
study was done in a hypertensive patient with a unilateral nephrotosis.
The Rb/Kr ratio measured over the contralateral nonptotic kidney
showed no significant change when the patient moved from supine to
upright position. The ratio over the ptotic kidney, however, showed a
significant fall followed by a gradual rise. Conclusion. The 8IRb/sImKr
ratio method appears to be a valuable tool for the qualitative measure-
ment of RBF changes. Future research should focus on the interference
of the 8tRb redistribution in order to facilitate a more accurate quantita-
tive use of the 8IRb/slmKr ratio method.
